塩野義製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/01/07 | 5,680 | 5,788 | 5,680 | 5,736 | +142 | +2.5% | 1,624,000 |
2021/01/06 | 5,531 | 5,599 | 5,508 | 5,594 | +52 | +0.9% | 869,100 |
2021/01/05 | 5,634 | 5,634 | 5,526 | 5,542 | -85 | -1.5% | 838,800 |
2021/01/04 | 5,643 | 5,689 | 5,572 | 5,627 | -8 | -0.1% | 832,100 |
2020/12/30 | 5,712 | 5,712 | 5,630 | 5,635 | -44 | -0.8% | 804,100 |
2020/12/29 | 5,564 | 5,695 | 5,561 | 5,679 | +123 | +2.2% | 982,700 |
2020/12/28 | 5,542 | 5,602 | 5,514 | 5,556 | +39 | +0.7% | 689,500 |
2020/12/25 | 5,580 | 5,580 | 5,511 | 5,517 | -25 | -0.5% | 317,000 |
2020/12/24 | 5,545 | 5,568 | 5,527 | 5,542 | -31 | -0.6% | 480,000 |
2020/12/23 | 5,595 | 5,605 | 5,556 | 5,573 | -3 | -0.1% | 560,900 |
2020/12/22 | 5,570 | 5,606 | 5,545 | 5,576 | -64 | -1.1% | 718,100 |
2020/12/21 | 5,705 | 5,725 | 5,588 | 5,640 | -14 | -0.2% | 907,200 |
2020/12/18 | 5,562 | 5,674 | 5,541 | 5,654 | +75 | +1.3% | 1,464,400 |
2020/12/17 | 5,689 | 5,709 | 5,570 | 5,579 | +140 | +2.6% | 2,827,600 |
2020/12/16 | 5,519 | 5,533 | 5,436 | 5,439 | -53 | -1% | 800,800 |
2020/12/15 | 5,568 | 5,582 | 5,488 | 5,492 | -58 | -1% | 924,900 |
2020/12/14 | 5,560 | 5,604 | 5,549 | 5,550 | -57 | -1% | 980,600 |
2020/12/11 | 5,620 | 5,666 | 5,581 | 5,607 | -13 | -0.2% | 1,043,000 |
2020/12/10 | 5,609 | 5,642 | 5,570 | 5,620 | +20 | +0.4% | 857,400 |
2020/12/09 | 5,601 | 5,673 | 5,575 | 5,600 | +9 | +0.2% | 918,100 |
2020/12/08 | 5,615 | 5,617 | 5,572 | 5,591 | -64 | -1.1% | 638,100 |
2020/12/07 | 5,623 | 5,669 | 5,605 | 5,655 | +45 | +0.8% | 549,500 |
2020/12/04 | 5,539 | 5,622 | 5,525 | 5,610 | +14 | +0.3% | 791,900 |
2020/12/03 | 5,596 | 5,642 | 5,571 | 5,596 | +6 | +0.1% | 1,281,900 |
2020/12/02 | 5,626 | 5,673 | 5,579 | 5,590 | -37 | -0.7% | 1,061,600 |
2020/12/01 | 5,630 | 5,687 | 5,602 | 5,627 | +34 | +0.6% | 686,000 |
2020/11/30 | 5,723 | 5,745 | 5,593 | 5,593 | -119 | -2.1% | 2,305,200 |
2020/11/27 | 5,729 | 5,753 | 5,681 | 5,712 | +12 | +0.2% | 1,096,500 |
2020/11/26 | 5,660 | 5,702 | 5,594 | 5,700 | +7 | +0.1% | 747,100 |
2020/11/25 | 5,723 | 5,768 | 5,687 | 5,693 | +115 | +2.1% | 1,345,800 |
2020/11/24 | 5,597 | 5,655 | 5,578 | 5,578 | +21 | +0.4% | 1,118,700 |
2020/11/20 | 5,561 | 5,609 | 5,530 | 5,557 | -45 | -0.8% | 1,068,300 |
2020/11/19 | 5,597 | 5,611 | 5,524 | 5,602 | -28 | -0.5% | 1,141,500 |
2020/11/18 | 5,553 | 5,685 | 5,549 | 5,630 | -10 | -0.2% | 888,500 |
2020/11/17 | 5,627 | 5,672 | 5,597 | 5,640 | +18 | +0.3% | 1,114,000 |
2020/11/16 | 5,607 | 5,688 | 5,585 | 5,622 | +10 | +0.2% | 880,100 |
2020/11/13 | 5,651 | 5,652 | 5,567 | 5,612 | -12 | -0.2% | 1,228,900 |
2020/11/12 | 5,698 | 5,735 | 5,562 | 5,624 | -156 | -2.7% | 1,805,400 |
2020/11/11 | 5,714 | 5,798 | 5,675 | 5,780 | +214 | +3.8% | 1,609,200 |
2020/11/10 | 5,675 | 5,690 | 5,541 | 5,566 | -34 | -0.6% | 1,253,700 |
2020/11/09 | 5,589 | 5,625 | 5,530 | 5,600 | +47 | +0.8% | 1,238,600 |
2020/11/06 | 5,498 | 5,582 | 5,442 | 5,553 | -27 | -0.5% | 1,444,900 |
2020/11/05 | 5,525 | 5,635 | 5,511 | 5,580 | +285 | +5.4% | 2,569,600 |
2020/11/04 | 5,259 | 5,324 | 5,181 | 5,295 | +142 | +2.8% | 1,591,400 |
2020/11/02 | 5,020 | 5,184 | 4,994 | 5,153 | +229 | +4.7% | 1,428,800 |
2020/10/30 | 4,880 | 5,039 | 4,761 | 4,924 | +39 | +0.8% | 1,919,200 |
2020/10/29 | 4,855 | 4,910 | 4,827 | 4,885 | -1 | ±0% | 748,300 |
2020/10/28 | 4,928 | 4,943 | 4,861 | 4,886 | -96 | -1.9% | 802,100 |
2020/10/27 | 5,040 | 5,045 | 4,957 | 4,982 | -53 | -1.1% | 712,300 |
2020/10/26 | 5,059 | 5,094 | 5,025 | 5,035 | -24 | -0.5% | 419,800 |
951~
1000
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「塩野義」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
塩野義 | 209,400円 | +5.7% | +3.9% | 2.74% | 10.42倍 | 1.38倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
大塚HD | 891,000円 | +14.4% | +120.8% | 1.35% | 20.00倍 | 1.83倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 156,200円 | +12.2% | +180.3% | 4.74% | 55.93倍 | 1.83倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
エーザイ | 465,000円 | +1.7% | -2.9% | 3.44% | 30.51倍 | 1.60倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
協和キリン | 252,300円 | +11.3% | -5.4% | 2.30% | 19.42倍 | 1.53倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
市場注目の銘柄
チャート関連のコラム